Literature DB >> 28691786

Regulatory Review of New Therapeutic Agents.

Yasuhiro Fujiwara1, Shunsuke Ono2.   

Abstract

Mesh：

Year:  2017        PMID： 28691786     DOI： 10.1056/NEJMc1705868

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project.

Authors:  Hitomi S Okuma; Yasuhiro Fujiwara
Journal:  Clin Pharmacol Ther       Date:  2019-05-23       Impact factor: 6.875

Review 2.  Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China.

Authors:  Takaaki Mizuno; Yuki Katsuya; Jun Sato; Takafumi Koyama; Toshio Shimizu; Noboru Yamamoto
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

3.  MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial.

Authors:  Hitomi S Okuma; Kan Yonemori; Shoko N Narita; Tamie Sukigara; Akihiro Hirakawa; Toshio Shimizu; Taro Shibata; Akira Kawai; Noboru Yamamoto; Kenichi Nakamura; Toshiro Nishida; Yasuhiro Fujiwara
Journal:  Clin Pharmacol Ther       Date:  2020-04-07       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.